SCHEMBL529911

SCHEMBL529911

O=C(O)C(O)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7524717 1.00
SCHEMBL7520045 1.00
SCHEMBL1404740 0.75
SCHEMBL1404687 0.75
SCHEMBL8846632 0.75
SCHEMBL1672546 0.72
SCHEMBL3261082 0.72 TET2 (0.67)
SCHEMBL6054264 0.72 TET2 (0.67)
SCHEMBL19331462 0.72 OR51E2 (0.59)
SCHEMBL728172 0.72 OR51E2 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11447802-B2 Microorganisms and processes for lactic acid production PTT GLOBAL CHEMICAL PUBLIC COMPANY LIMITED (TH) 2022-09-20 US claimed
US-20210017551-A1 MICROORGANISMS AND PROCESSES FOR LACTIC ACID PRODUCTION PTT GLOBAL CHEMICAL PUBLIC COMPANY LIMITED (TH) 2021-01-21 US claimed
EP-3752627-A2 MICROORGANISMS AND PROCESSES FOR LACTIC ACID PRODUCTION PTT Global Chemical Public Company Limited (TH) 2020-12-23 EP claimed
CN-112074606-A Microorganisms and processes for lactic acid production PTT全球化学股份有限公司 2020-12-11 CN claimed
WO-2019159011-A2 MICROORGANISMS AND PROCESSES FOR LACTIC ACID PRODUCTION PTT GLOBAL CHEMICAL PUBLIC COMPANY LIMITED (TH) 2019-08-22 WO claimed
EP-2391363-B1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER KO YOUNG HEE (US) 2016-09-28 EP claimed
WO-2010088564-A2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER KO YOUNG HEE (US) 2010-08-05 WO claimed
US-20260027074-A1 ANIMAL THERAPEUTIC COMPOSITION AND ASSOCIATED METHODS KODISCOVERY LLC (US) 2026-01-29 US disclosed
US-20260014106-A1 COMBINATION IMMUNORESPONSE REGULATOR/IMMUNOTHERAPY SYSTEM AND METHOD KODISCOVERY LLC (US) 2026-01-15 US disclosed
EP-4626440-A1 HEAVY ISOTOPE 3-BP MOLECULES, COMPOSITIONS, AND TREATMENTS KoDiscovery, LLC (US) 2025-10-08 EP disclosed
US-20250295616-A1 A SYSTEM AND METHOD FOR COMPARTMENTALIZED INGREDIENTS FOR A LIQUID PHARMACEUTICAL FORMULATION KODISCOVERY LLC (US) 2025-09-25 US disclosed
US-20250248956-A1 LIQUID-DISPERSIBLE HALOPYRUVATE FORMULATIONS AND ASSOCIATED METHODS KO YOUNG HEE (US) 2025-08-07 US disclosed
CN-120076812-A System and method for compartmentalization of ingredients for liquid pharmaceutical formulations 科迪斯克维利公司 2025-05-30 CN disclosed
WO-2012018949-A2 COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER KO YOUNG HEE (US) 2012-02-09 WO disclosed
WO-2012015481-A1 FUNCTIONAL BIODEGRADABLE POLYMERS UNIVERSITY OF AKRON (US) 2012-02-02 WO disclosed
US-8022042-B2 Composition and methods for the treatment of cancer KODISCOVERY, LLC 2011-09-20 US disclosed
US-20110008418-A1 Compositions and Methods for the Treatment of Cancer KODISCOVERY, LLC 2011-01-13 US disclosed
US-20100197612-A1 Composition and Methods for the Treatment of Cancer KODISCOVERY, LLC 2010-08-05 US disclosed
US-20020042055-A1 Alteration of hydrolase genes and screening of the resulting libraries for the ability to catalyze specific reactions MAXYGEN, INC. 2002-04-11 US disclosed
WO-2001046476-A1 ALTERATION OF HYDROLASE GENES AND SCREENING OF THE RESULTING LIBRARIES FOR THE ABILITY TO CATALYZE SPECIFIC REACTIONS MAXYGEN, INC. (US) 2001-06-28 WO disclosed